Aridis Pharmaceuticals, Inc. Quarterly Current Ratio in % from Q1 2019 to Q3 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Aridis Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q1 2019 to Q3 2023.
  • Aridis Pharmaceuticals, Inc. Current Ratio for the quarter ending September 30, 2023 was 23.8 %, a 45.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 23.8 -20.1 -45.8% Sep 30, 2023
Q2 2023 22.8 -36.1 -61.3% Jun 30, 2023
Q1 2023 26 -36.9 -58.7% Mar 31, 2023
Q4 2022 34.5 -30.6 -47% Dec 31, 2022
Q3 2022 43.8 -16.7 -27.6% Sep 30, 2022
Q2 2022 58.9 +6.14 +11.6% Jun 30, 2022
Q1 2022 62.9 -1.52 -2.36% Mar 31, 2022
Q4 2021 65 -9.91 -13.2% Dec 31, 2021
Q3 2021 60.5 -34.8 -36.5% Sep 30, 2021
Q2 2021 52.8 -88 -62.5% Jun 30, 2021
Q1 2021 64.4 -108 -62.7% Mar 31, 2021
Q4 2020 75 -168 -69.1% Dec 31, 2020
Q3 2020 95.3 -304 -76.1% Sep 30, 2020
Q2 2020 141 -306 -68.5% Jun 30, 2020
Q1 2020 173 -278 -61.7% Mar 31, 2020
Q4 2019 243 Dec 31, 2019
Q3 2019 399 Sep 30, 2019
Q2 2019 447 Jun 30, 2019
Q1 2019 450 Mar 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.